Edward Adomako: Recognizing Thrombotic Thrombocytopenic Purpura as A Life-Threatening Emergency
Edward Adomako, Biochemist and Molecular Biologist, shared on LinkedIn:
”Thrombotic Thrombocytopenic Purpura (TTP): A Rare but Life-Threatening Medical Emergency
In clinical laboratory medicine, some conditions demand rapid recognition and immediate intervention.
One of these is Thrombotic Thrombocytopenic Purpura (TTP), a rare disorder that can become fatal if not treated promptly.
TTP occurs when there is a severe deficiency of the enzyme ADAMTS13, which normally regulates von Willebrand factor in the blood.
When this enzyme is lacking, abnormal platelet clumping can occur in small blood vessels, leading to microvascular thrombosis.
Key laboratory and clinical features include:
- Severe thrombocytopenia (low platelet count)
- Microangiopathic hemolytic anemia with schistocytes on peripheral smear
- Elevated LDH and bilirubin
- Neurological symptoms such as confusion or seizures
- Possible renal impairment
Historically, clinicians described a ‘pentad’ of symptoms, but in many cases, the combination of thrombocytopenia and hemolytic anemia is enough to raise strong suspicion.
Why early diagnosis matters
Without treatment, mortality from TTP can be extremely high.c
Fortunately, modern therapies such as therapeutic plasma exchange, corticosteroids, and targeted therapies like caplacizumab have dramatically improved survival rates.
The role of the laboratory
Laboratory professionals play a critical role in identifying:
- Schistocytes on peripheral blood smear
- Evidence of hemolysis
- ADAMTS13 activity testing when available
Early laboratory detection can be the difference between rapid life-saving treatment and delayed care.
For healthcare professionals:
Maintaining a high index of suspicion when encountering unexplained thrombocytopenia and hemolytic anemia is crucial.
As laboratory and healthcare professionals, our vigilance helps ensure that rare but critical conditions like TTP are recognized and treated in time.”
Stay updated with Hemostasis Today.
-
Apr 17, 2026, 09:54Andrew Aswani: How NETs Contribute to Disease and Why They Matter
-
Apr 17, 2026, 09:49Jeevandeep Mishra: Thrombotic Complications and Risk in COVID-19
-
Apr 17, 2026, 09:25The Challanges of Cancer-Associated Thrombosis – ISTH
-
Apr 17, 2026, 08:32Leslie Johns: Our First Low Titer O Whole Blood Products
-
Apr 17, 2026, 08:24Dominique P. Germain: The Critical Role of Cardiac Involvement in Fabry Disease
-
Apr 17, 2026, 07:54Pat Garcia-Gonzalez: Does Having Lifesaving Medicine at a Hospital Guarantee Patient Access?
-
Apr 17, 2026, 05:41Tareq Abadl: Sickle Cell Anemia is Not Just Hemoglobin Deficiency, It’s a Genetic Mutation
-
Apr 17, 2026, 04:58Emmanuel J Favaloro: A Century of von Willebrand Disease – From Discovery to Modern Diagnostic Pathways
-
Apr 17, 2026, 02:41Helena Bradbury: First Haematology EAHAD Supplement of 2026